| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC1 MYH7 MYH8 HSPA4L TOR2A ABCA12 ATAD5 ZNFX1 NAE1 ATP6V1D ATAD2B DNAH17 RAD17 | 9.08e-05 | 614 | 121 | 13 | GO:0140657 |
| GeneOntologyBiologicalProcess | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) | 1.57e-05 | 26 | 122 | 4 | GO:0000466 | |
| GeneOntologyBiologicalProcess | centrosome localization | 5.29e-05 | 35 | 122 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane neurotransmitter receptor levels | 5.50e-05 | 164 | 122 | 7 | GO:0099072 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 5.93e-05 | 36 | 122 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | maturation of 5.8S rRNA | 6.62e-05 | 37 | 122 | 4 | GO:0000460 | |
| Domain | ARM-type_fold | PDS5B NBEAL1 ZNFX1 DOCK5 AP4E1 VAC14 NCAPG NF1 PIK3C2A USO1 CEBPZ EIF4G1 ASPM UTP20 WDFY3 | 4.22e-09 | 339 | 119 | 15 | IPR016024 |
| Domain | - | 8.89e-05 | 222 | 119 | 8 | 1.25.10.10 | |
| Domain | srGAP2 | 1.20e-04 | 3 | 119 | 2 | IPR030252 | |
| Domain | Myosin-like_IQ_dom | 2.27e-04 | 19 | 119 | 3 | IPR027401 | |
| Domain | - | 2.27e-04 | 19 | 119 | 3 | 4.10.270.10 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | IPR012315 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | PS51049 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | SM01249 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | PF10541 | |
| Domain | AAA | 3.21e-04 | 144 | 119 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 3.21e-04 | 144 | 119 | 6 | IPR003593 | |
| Domain | ARM-like | 3.38e-04 | 270 | 119 | 8 | IPR011989 | |
| Domain | FCH | 3.56e-04 | 22 | 119 | 3 | PF00611 | |
| Domain | FCH | 3.56e-04 | 22 | 119 | 3 | SM00055 | |
| Domain | DUF4704 | 3.98e-04 | 5 | 119 | 2 | IPR031570 | |
| Domain | DUF4704 | 3.98e-04 | 5 | 119 | 2 | PF15787 | |
| Domain | Spectrin | 4.07e-04 | 23 | 119 | 3 | PF00435 | |
| Domain | FCH_dom | 4.07e-04 | 23 | 119 | 3 | IPR001060 | |
| Domain | Keratin_2_head | 4.63e-04 | 24 | 119 | 3 | IPR032444 | |
| Domain | Keratin_2_head | 4.63e-04 | 24 | 119 | 3 | PF16208 | |
| Domain | F_BAR | 5.24e-04 | 25 | 119 | 3 | IPR031160 | |
| Domain | F_BAR | 5.24e-04 | 25 | 119 | 3 | PS51741 | |
| Domain | Keratin_II | 5.89e-04 | 26 | 119 | 3 | IPR003054 | |
| Domain | TRP_2 | 5.94e-04 | 6 | 119 | 2 | PF08344 | |
| Domain | PIN_dom | 5.94e-04 | 6 | 119 | 2 | IPR002716 | |
| Domain | PH_BEACH | 5.94e-04 | 6 | 119 | 2 | PF14844 | |
| Domain | TRP_dom | 5.94e-04 | 6 | 119 | 2 | IPR013555 | |
| Domain | PINc | 5.94e-04 | 6 | 119 | 2 | SM00670 | |
| Domain | Intermediate_filament_CS | 6.98e-04 | 63 | 119 | 4 | IPR018039 | |
| Domain | Spectrin_repeat | 8.17e-04 | 29 | 119 | 3 | IPR002017 | |
| Domain | TRPC_channel | 8.28e-04 | 7 | 119 | 2 | IPR002153 | |
| Domain | HEAT_REPEAT | 1.04e-03 | 70 | 119 | 4 | PS50077 | |
| Domain | SPEC | 1.09e-03 | 32 | 119 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.09e-03 | 32 | 119 | 3 | IPR018159 | |
| Domain | Filament | 1.10e-03 | 71 | 119 | 4 | SM01391 | |
| Domain | PH-BEACH_dom | 1.10e-03 | 8 | 119 | 2 | IPR023362 | |
| Domain | - | 1.10e-03 | 8 | 119 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 1.10e-03 | 8 | 119 | 2 | PS51783 | |
| Domain | IF | 1.15e-03 | 72 | 119 | 4 | PS00226 | |
| Domain | Filament | 1.22e-03 | 73 | 119 | 4 | PF00038 | |
| Domain | BEACH | 1.41e-03 | 9 | 119 | 2 | PS50197 | |
| Domain | Beach | 1.41e-03 | 9 | 119 | 2 | PF02138 | |
| Domain | - | 1.41e-03 | 9 | 119 | 2 | 1.10.1540.10 | |
| Domain | Beach | 1.41e-03 | 9 | 119 | 2 | SM01026 | |
| Domain | BEACH_dom | 1.41e-03 | 9 | 119 | 2 | IPR000409 | |
| Domain | IF | 1.41e-03 | 76 | 119 | 4 | IPR001664 | |
| Domain | TRP_channel | 2.13e-03 | 11 | 119 | 2 | IPR004729 | |
| Domain | BAH | 2.13e-03 | 11 | 119 | 2 | PS51038 | |
| Domain | BAH_dom | 2.13e-03 | 11 | 119 | 2 | IPR001025 | |
| Domain | BAH | 2.13e-03 | 11 | 119 | 2 | SM00439 | |
| Domain | BAH | 2.13e-03 | 11 | 119 | 2 | PF01426 | |
| Domain | - | 2.55e-03 | 12 | 119 | 2 | 3.40.50.1010 | |
| Domain | MAPK | 2.55e-03 | 12 | 119 | 2 | PS01351 | |
| Domain | MAP_kinase_CS | 2.55e-03 | 12 | 119 | 2 | IPR003527 | |
| Domain | ZnF_GATA | 2.55e-03 | 12 | 119 | 2 | SM00401 | |
| Domain | ELM2_dom | 3.00e-03 | 13 | 119 | 2 | IPR000949 | |
| Domain | ELM2 | 3.00e-03 | 13 | 119 | 2 | PF01448 | |
| Domain | ELM2 | 3.00e-03 | 13 | 119 | 2 | PS51156 | |
| Domain | ELM2 | 3.00e-03 | 13 | 119 | 2 | SM01189 | |
| Domain | PIN_domain-like | 3.48e-03 | 14 | 119 | 2 | IPR029060 | |
| Domain | HEAT | 3.54e-03 | 48 | 119 | 3 | PF02985 | |
| Domain | Znf_GATA | 4.00e-03 | 15 | 119 | 2 | IPR000679 | |
| Domain | Myosin_N | 4.00e-03 | 15 | 119 | 2 | PF02736 | |
| Domain | GATA | 4.00e-03 | 15 | 119 | 2 | PF00320 | |
| Domain | Myosin_N | 4.00e-03 | 15 | 119 | 2 | IPR004009 | |
| Domain | GATA_ZN_FINGER_1 | 4.56e-03 | 16 | 119 | 2 | PS00344 | |
| Domain | GATA_ZN_FINGER_2 | 4.56e-03 | 16 | 119 | 2 | PS50114 | |
| Domain | Myosin_tail_1 | 5.76e-03 | 18 | 119 | 2 | PF01576 | |
| Domain | Myosin_tail | 5.76e-03 | 18 | 119 | 2 | IPR002928 | |
| Domain | HEAT | 6.03e-03 | 58 | 119 | 3 | IPR000357 | |
| Pubmed | SCFD2 TNIK HSPA4L ATAD5 DNAJC8 SYNE1 UGGT1 SPTLC1 SPART EXOSC8 RPS23 ZFC3H1 NBAS NCAPG SYNE3 AKAP9 TMTC3 PIK3C2A CEBPZ CCDC47 P3H1 NAE1 GKAP1 ASPM TACC1 DNAJA1 FTSJ3 | 2.27e-12 | 1487 | 124 | 27 | 33957083 | |
| Pubmed | PDS5B KRT6A KRT6B MYH7 MYH8 HSPA4L PTBP2 TRO SYNE1 UGGT1 GPS1 RPS23 ACTN2 ZFC3H1 NEFL LATS1 KRT6C CEBPZ CCDC47 EIF4G1 CEP83 ASPM CADPS2 DNAJA1 DNMT3B | 4.52e-11 | 1442 | 124 | 25 | 35575683 | |
| Pubmed | MTA2 PDS5B PTBP2 UGGT1 SENP3 GPS1 SPART SIN3A PGM3 NCAPG MTA1 USO1 EIF4G1 DNAJA1 | 1.44e-08 | 560 | 124 | 14 | 35241646 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TNIK PDS5B GPS1 SPTLC1 EXOSC8 RPS23 SIN3A PGM3 NBAS NCAPG USO1 CEBPZ CCDC47 UTP20 DNAJA1 | 3.52e-08 | 704 | 124 | 15 | 29955894 |
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 29357356 | ||
| Pubmed | 4.42e-08 | 3 | 124 | 3 | 7543104 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KRT6A ATAD5 SPART EXOSC8 SRGAP2 ZFC3H1 CHMP4B GSN MTA1 PIK3C2A RBM27 CEBPZ EIF4G1 GKAP1 DNAJA1 | 5.07e-08 | 724 | 124 | 15 | 36232890 |
| Pubmed | 8.04e-08 | 101 | 124 | 7 | 26949739 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | MTA2 PDS5B ATAD5 SENP3 EXOSC8 SIN3A ZFC3H1 MCM10 RBM27 CEBPZ EIF4G1 ASPM UTP20 DNAJA1 FTSJ3 | 9.34e-08 | 759 | 124 | 15 | 35915203 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MTA2 MYH7 HSPA4L UGGT1 SPART EXOSC8 RPS23 SRGAP2 GSN NEFL VAC14 MTA1 RBM27 USO1 NAE1 EIF4G1 DNAJA1 FTSJ3 | 1.45e-07 | 1149 | 124 | 18 | 35446349 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B MYH7 HSPA4L UGGT1 GPS1 SPTLC1 ALS2 SRGAP2 GSN VAC14 NCAPG USO1 CCDC47 NAE1 EIF4G1 ASPM IRS2 DNAJA1 FTSJ3 | 1.52e-07 | 1284 | 124 | 19 | 17353931 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDS5B ABCC1 HSPA4L GPS1 SPTLC1 PGM3 VAC14 NCAPG TMTC3 USO1 CEBPZ CCDC47 P3H1 EIF4G1 UTP20 DNAJA1 | 2.62e-07 | 942 | 124 | 16 | 31073040 |
| Pubmed | TNIK SYNE1 TRPC4 SENP3 ARHGEF18 ZNFX1 SRGAP2 GSN NEFL NF1 AKAP9 EIF4G1 WDFY3 DNAJA1 GOLGA2 PROX1 | 3.51e-07 | 963 | 124 | 16 | 28671696 | |
| Pubmed | TNIK ABCC1 GRIPAP1 UGGT1 ARHGEF18 SRGAP2 MCM10 NBAS TMTC3 USO1 CEBPZ CCDC47 TACC1 DNAJA1 | 3.88e-07 | 733 | 124 | 14 | 34672954 | |
| Pubmed | 4.40e-07 | 5 | 124 | 3 | 20301457 | ||
| Pubmed | Defective myogenesis in the absence of the muscle-specific lysine methyltransferase SMYD1. | 4.53e-07 | 18 | 124 | 4 | 26688546 | |
| Pubmed | MTA2 ABCC1 HSPA4L GPS1 OR10V1 SPTLC1 SPART EXOSC8 NCAPG MTA1 USO1 CCDC47 P3H1 NAE1 EIF4G1 | 5.94e-07 | 878 | 124 | 15 | 37223481 | |
| Pubmed | KRT6A GRIPAP1 SRGAP2 CHMP4B GSN USO1 ATP6V1D EIF4G1 GOLGA2 PROX1 | 7.15e-07 | 360 | 124 | 10 | 33111431 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MTA2 PDS5B HSPA4L DNAJC8 SYNE1 UGGT1 SPTLC1 LAMC3 RPS23 CHMP4B NCAPG NF1 USO1 CEBPZ CCDC47 EIF4G1 UTP20 DNAJA1 FTSJ3 | 7.37e-07 | 1425 | 124 | 19 | 30948266 |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | SCFD2 ABCC1 UGGT1 SPTLC1 PANX1 NBAS SYNE3 TMTC3 CCDC47 TACC1 DNAJA1 | 1.01e-06 | 468 | 124 | 11 | 31056421 |
| Pubmed | NBEAL1 GPS1 RPS23 SRGAP2 DTX3L CYTL1 MCM10 QSOX1 SYNE3 AKAP9 CCDC47 PRORP RAD17 | 1.19e-06 | 689 | 124 | 13 | 36543142 | |
| Pubmed | 1.33e-06 | 53 | 124 | 5 | 34026424 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | MTA2 PDS5B HSPA4L ATAD5 SENP3 SIN3A NCAPG RBM27 DNAJA1 FTSJ3 | 1.61e-06 | 394 | 124 | 10 | 27248496 |
| Pubmed | 2.28e-06 | 59 | 124 | 5 | 26371508 | ||
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 15148359 | ||
| Pubmed | 2.45e-06 | 8 | 124 | 3 | 33294854 | ||
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MTA2 KRT6A KRT6B UGGT1 SENP3 EXOSC8 RPS23 ZFC3H1 GSN RBM27 CEBPZ SRGAP1 EIF4G1 UTP20 DNAJA1 GOLGA2 FTSJ3 | 2.48e-06 | 1257 | 124 | 17 | 36526897 |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | KRT6A PTBP2 SPART EXOSC8 ALS2 ACTN2 UCK1 NEFL VAC14 GKAP1 TACC1 FLACC1 GOLGA2 | 2.67e-06 | 742 | 124 | 13 | 26871637 |
| Pubmed | DNAJC8 SENP3 EXOSC8 RPS23 FCF1 GTF2H2 CEBPZ UTP20 DNAJA1 FTSJ3 | 2.79e-06 | 419 | 124 | 10 | 15635413 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | KRT6A KRT6B HSPA4L UGGT1 RPS23 SRGAP2 SIN3A GSN NCAPG KRT6C USO1 CEBPZ CCDC47 EIF4G1 IRS2 DNAJA1 GOLGA2 FTSJ3 | 2.88e-06 | 1415 | 124 | 18 | 28515276 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | MTA2 ABCC1 ATAD5 SENP3 SREBF1 RPS23 SIN3A ZFC3H1 DOCK5 MTA1 TMTC3 RBM27 CEBPZ UTP20 TIGD5 DNAJA1 FTSJ3 | 3.65e-06 | 1294 | 124 | 17 | 30804502 |
| Pubmed | MTA2 PDS5B UGGT1 RPS23 NEFL NF1 CEBPZ ATAD2B EIF4G1 UTP20 DNAJA1 FTSJ3 | 4.08e-06 | 653 | 124 | 12 | 22586326 | |
| Pubmed | MTA2 ABCC1 KRT6A ACOX1 PANX1 RPS23 NBAS NCAPG SYNE3 NF1 PIK3C2A USO1 CCDC47 P3H1 EIF4G1 DNAJA1 | 4.28e-06 | 1168 | 124 | 16 | 19946888 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 4.77e-06 | 120 | 124 | 6 | 31413325 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MTA2 ABCC1 HSPA4L UGGT1 GPS1 SPTLC1 SREBF1 LAMC3 VAC14 NF1 TMTC3 CCDC47 P3H1 NAE1 UTP20 GOLGA2 | 6.08e-06 | 1201 | 124 | 16 | 35696571 |
| Pubmed | SCFD2 NBEAL1 SPART CHMP4B NBAS RBM27 CCDC47 MTFR1 EIF4G1 TACC1 GOLGA2 | 6.42e-06 | 568 | 124 | 11 | 37774976 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 PDS5B KRT6B SENP3 RPS23 MCM10 NCAPG NF1 PIK3C2A CEBPZ CCDC47 EIF4G1 ASPM UTP20 WDFY3 DNAJA1 FTSJ3 | 6.57e-06 | 1353 | 124 | 17 | 29467282 |
| Pubmed | 7.15e-06 | 11 | 124 | 3 | 15456747 | ||
| Pubmed | 7.23e-06 | 197 | 124 | 7 | 23686814 | ||
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | MTA2 GRIPAP1 UGGT1 GPS1 SPART EXOSC8 RPS23 SIN3A CHMP4B GSN NCAPG PIK3C2A USO1 CCDC47 NAE1 EIF4G1 DNAJA1 | 7.51e-06 | 1367 | 124 | 17 | 32687490 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | 7.67e-06 | 370 | 124 | 9 | 22922362 | |
| Pubmed | TNIK MTA2 KRT6A UGGT1 RPS23 CHMP4B FCF1 GTF2H2 AKAP9 PIK3C2A RBM27 USO1 CEBPZ CCDC47 EIF4G1 GOLGA2 FTSJ3 | 7.80e-06 | 1371 | 124 | 17 | 36244648 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 8.06e-06 | 281 | 124 | 8 | 28706196 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 8.52e-06 | 202 | 124 | 7 | 33005030 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | TNIK PDS5B SGSM1 DNAJC8 ARHGEF18 LAMC3 UCK1 AP4E1 GTF2H2 MTA1 NF1 AKAP9 DNAH17 ASPM PRKCZ MAPK10 | 9.24e-06 | 1242 | 124 | 16 | 30973865 |
| Pubmed | 9.51e-06 | 12 | 124 | 3 | 9885572 | ||
| Pubmed | 9.51e-06 | 12 | 124 | 3 | 23708667 | ||
| Pubmed | 9.68e-06 | 483 | 124 | 10 | 36912080 | ||
| Pubmed | 1.10e-05 | 210 | 124 | 7 | 16565220 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MTA2 GRIPAP1 HSPA4L DNAJC8 PTBP2 TRO RPS23 NEFL NCAPG MTA1 ATP6V1D EIF4G1 DNAJA1 | 1.11e-05 | 847 | 124 | 13 | 35235311 |
| Pubmed | 1.23e-05 | 13 | 124 | 3 | 12920132 | ||
| Pubmed | A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. | 1.23e-05 | 13 | 124 | 3 | 11586298 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 7926784 | ||
| Pubmed | Differential distribution of TRP Ca2+ channel isoforms in mouse brain. | 1.26e-05 | 2 | 124 | 2 | 9512398 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 33984363 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 35584682 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10550543 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10550545 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 28576728 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 22982304 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9790766 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 9150144 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11489919 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10953016 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 6207530 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 16537542 | ||
| Pubmed | Cytoskeletal interactions at the nuclear envelope mediated by nesprins. | 1.26e-05 | 2 | 124 | 2 | 22518138 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11118885 | ||
| Pubmed | Microtubule nucleation at the cis-side of the Golgi apparatus requires AKAP450 and GM130. | 1.26e-05 | 2 | 124 | 2 | 19242490 | |
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 30642362 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 11856890 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 23662636 | ||
| Pubmed | 1.26e-05 | 2 | 124 | 2 | 10866680 | ||
| Pubmed | Cytokeratins mediate epithelial innate defense through their antimicrobial properties. | 1.26e-05 | 2 | 124 | 2 | 23006328 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.40e-05 | 218 | 124 | 7 | 33378226 | |
| Pubmed | 1.47e-05 | 146 | 124 | 6 | 21589869 | ||
| Pubmed | DNAJC8 UGGT1 SPTLC1 SPART MCM10 LATS1 TMTC3 PIK3C2A RBM27 USO1 CCDC47 P3H1 TACC1 GOLGA2 | 1.51e-05 | 1007 | 124 | 14 | 34597346 | |
| Pubmed | 1.56e-05 | 14 | 124 | 3 | 20585571 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ABCC1 GRIPAP1 UGGT1 SPART EXOSC8 GSN LATS1 AKAP9 CEBPZ UTP20 GOLGA2 FTSJ3 | 1.72e-05 | 754 | 124 | 12 | 33060197 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 PDS5B KRT6A SYNE1 UGGT1 GSN NEFL NF1 KRT6C CEBPZ EIF4G1 UTP20 DNAJA1 FTSJ3 | 1.82e-05 | 1024 | 124 | 14 | 24711643 |
| Pubmed | SCFD2 ATAD5 SENP3 ZNFX1 NF1 TMTC3 CCDC47 PHACTR3 IRS2 TIGD5 WDFY3 | 1.89e-05 | 638 | 124 | 11 | 31182584 | |
| Pubmed | Prox1 maintains muscle structure and growth in the developing heart. | 1.95e-05 | 15 | 124 | 3 | 19091769 | |
| Pubmed | 1.97e-05 | 230 | 124 | 7 | 35449600 | ||
| Pubmed | 2.14e-05 | 156 | 124 | 6 | 29961565 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MTA2 MYH7 MYH8 HSPA4L SIN3A AXIN2 GTF2H2 LATS1 NF1 AKAP9 EIF4G1 MAPK11 GOLGA2 | 2.34e-05 | 910 | 124 | 13 | 36736316 |
| Pubmed | 2.39e-05 | 16 | 124 | 3 | 22090424 | ||
| Pubmed | ATAD5 DNAJC8 SYNE1 SENP3 EXOSC8 SRGAP2 ZFC3H1 CHMP4B MTA1 PIK3C2A RBM27 CEBPZ CCDC47 MTFR1 EIF4G1 CEP83 UTP20 | 2.41e-05 | 1497 | 124 | 17 | 31527615 | |
| Pubmed | 2.88e-05 | 244 | 124 | 7 | 30349055 | ||
| Pubmed | 2.90e-05 | 17 | 124 | 3 | 27806305 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 3.24e-05 | 168 | 124 | 6 | 30631154 | |
| Pubmed | A Y2H-seq approach defines the human protein methyltransferase interactome. | 3.30e-05 | 342 | 124 | 8 | 23455924 | |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | 3.42e-05 | 560 | 124 | 10 | 21653829 | |
| Pubmed | 3.47e-05 | 18 | 124 | 3 | 9790534 | ||
| Pubmed | 3.47e-05 | 18 | 124 | 3 | 12493763 | ||
| Pubmed | 3.47e-05 | 18 | 124 | 3 | 10444591 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 22559944 | ||
| Pubmed | A-to-I RNA editing enzyme ADAR2 regulates light-induced circadian phase-shift. | 3.77e-05 | 3 | 124 | 2 | 30287844 | |
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 30718452 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 15601842 | ||
| Pubmed | 3.77e-05 | 3 | 124 | 2 | 19357831 | ||
| Interaction | DISC1 interactions | TNIK MYH7 GRIPAP1 SYNE1 SRGAP2 ACTN2 MCM10 PGM3 GSN AP4E1 AKAP9 DNAJA1 FLACC1 GOLGA2 | 3.03e-07 | 429 | 121 | 14 | int:DISC1 |
| Interaction | KDM1A interactions | TNIK MTA2 KRT6A KRT6B GRIPAP1 SIN3A ADARB1 NEFL NCAPG MTA1 AKAP9 USO1 TACC1 IRS2 FAM9A DNAJA1 GOLGA2 EPAS1 PROX1 | 3.30e-06 | 941 | 121 | 19 | int:KDM1A |
| Interaction | C9orf78 interactions | MTA2 PDS5B PTBP2 UGGT1 SENP3 GPS1 SPART SIN3A PGM3 NCAPG MTA1 USO1 EIF4G1 MAPK11 DNAJA1 | 4.70e-06 | 620 | 121 | 15 | int:C9orf78 |
| Interaction | HECTD1 interactions | MTA2 PDS5B HSPA4L ATAD5 SENP3 SREBF1 EXOSC8 SRGAP2 SIN3A ZFC3H1 MCM10 NCAPG RBM27 CEBPZ EIF4G1 ASPM UTP20 DNAJA1 FTSJ3 | 6.28e-06 | 984 | 121 | 19 | int:HECTD1 |
| Interaction | MYH8 interactions | 1.49e-05 | 52 | 121 | 5 | int:MYH8 | |
| Interaction | MAGEA9 interactions | 3.73e-05 | 208 | 121 | 8 | int:MAGEA9 | |
| Interaction | NOP56 interactions | TNIK ATAD5 DNAJC8 UGGT1 SENP3 ZFC3H1 MCM10 CHMP4B TMTC3 CEBPZ UTP20 FBXO32 FTSJ3 | 3.89e-05 | 570 | 121 | 13 | int:NOP56 |
| Interaction | AGAP2 interactions | 4.00e-05 | 210 | 121 | 8 | int:AGAP2 | |
| Interaction | GSE1 interactions | 4.05e-05 | 154 | 121 | 7 | int:GSE1 | |
| Interaction | DES interactions | 4.76e-05 | 158 | 121 | 7 | int:DES | |
| Interaction | EFNA3 interactions | 4.80e-05 | 108 | 121 | 6 | int:EFNA3 | |
| Interaction | DNAJC25 interactions | 5.50e-05 | 284 | 121 | 9 | int:DNAJC25 | |
| Interaction | SORBS2 interactions | 5.60e-05 | 111 | 121 | 6 | int:SORBS2 | |
| Interaction | LZTR1 interactions | 5.60e-05 | 111 | 121 | 6 | int:LZTR1 | |
| Interaction | FAM50B interactions | 5.94e-05 | 69 | 121 | 5 | int:FAM50B | |
| Interaction | PRNP interactions | HSPA4L NBEAL1 GPS1 RPS23 SRGAP2 DTX3L CYTL1 MCM10 PGM3 QSOX1 NEFL SYNE3 AKAP9 USO1 CCDC47 CCDC149 NAE1 PRORP RAD17 | 5.97e-05 | 1158 | 121 | 19 | int:PRNP |
| Interaction | NDEL1 interactions | 6.03e-05 | 164 | 121 | 7 | int:NDEL1 | |
| Interaction | DNMT3B interactions | 6.50e-05 | 114 | 121 | 6 | int:DNMT3B | |
| Interaction | LATS1 interactions | MTA2 KRT6A MYH7 MYH8 EXOSC8 LATS1 SYNE3 AKAP9 KRT6C GOLGA2 FTSJ3 | 7.02e-05 | 440 | 121 | 11 | int:LATS1 |
| Interaction | MYH4 interactions | 7.78e-05 | 73 | 121 | 5 | int:MYH4 | |
| Interaction | CENPA interactions | 9.35e-05 | 377 | 121 | 10 | int:CENPA | |
| Interaction | EFNA4 interactions | 9.90e-05 | 239 | 121 | 8 | int:EFNA4 | |
| Interaction | SIN3A interactions | MTA2 SENP3 SREBF1 SIN3A ADARB1 MTA1 PER2 GOLGA2 EPAS1 DNMT3B | 9.97e-05 | 380 | 121 | 10 | int:SIN3A |
| Interaction | MACROH2A1 interactions | MTA2 DNAJC8 SENP3 GPS1 SIN3A CHMP4B ADARB1 MTA1 FBXO32 DNAJA1 DNMT3B | 1.00e-04 | 458 | 121 | 11 | int:MACROH2A1 |
| Interaction | CHMP4BP1 interactions | 1.07e-04 | 3 | 121 | 2 | int:CHMP4BP1 | |
| Interaction | MORF4 interactions | 1.07e-04 | 3 | 121 | 2 | int:MORF4 | |
| Interaction | HDAC1 interactions | MTA2 MYH7 MYH8 GPS1 SREBF1 SIN3A NCAPG MTA1 AKAP9 USO1 CCDC47 IRS2 MAPK11 MAPK10 DNAJA1 EPAS1 DNMT3B FTSJ3 | 1.08e-04 | 1108 | 121 | 18 | int:HDAC1 |
| Interaction | GOLGA2 interactions | KRT6A KRT6B PTBP2 SIN3A ZFC3H1 MCM10 NEFL MTA1 LATS1 AKAP9 KRT6C USO1 ATP6V1D GOLGA2 | 1.30e-04 | 733 | 121 | 14 | int:GOLGA2 |
| Interaction | SUZ12 interactions | MTA2 SYNE1 SENP3 SREBF1 EXOSC8 SIN3A NEFL NCAPG MTA1 NF1 AKAP9 DNAJA1 DNMT3B | 1.33e-04 | 644 | 121 | 13 | int:SUZ12 |
| Interaction | TRPC6 interactions | 1.35e-04 | 82 | 121 | 5 | int:TRPC6 | |
| Interaction | EMC8 interactions | 1.61e-04 | 192 | 121 | 7 | int:EMC8 | |
| Interaction | LMBR1L interactions | PDS5B ABCC1 HSPA4L GPS1 SPTLC1 PGM3 VAC14 NCAPG TMTC3 USO1 CEBPZ CCDC47 P3H1 EIF4G1 UTP20 DNAJA1 | 1.72e-04 | 946 | 121 | 16 | int:LMBR1L |
| Interaction | TRIM28 interactions | TNIK MTA2 PDS5B SENP3 GPS1 SPTLC1 EXOSC8 RPS23 SIN3A PGM3 NBAS NCAPG PIK3C2A USO1 CEBPZ CCDC47 UTP20 PRKCZ DNAJA1 EPAS1 DNMT3B | 1.75e-04 | 1474 | 121 | 21 | int:TRIM28 |
| Interaction | TARS1 interactions | 1.78e-04 | 195 | 121 | 7 | int:TARS1 | |
| Interaction | MYH13 interactions | 1.96e-04 | 48 | 121 | 4 | int:MYH13 | |
| Interaction | PHTF1 interactions | 2.23e-04 | 20 | 121 | 3 | int:PHTF1 | |
| Interaction | ATG5 interactions | PDS5B GRIPAP1 HSPA4L DNAJC8 SPART DOCK5 PIK3C2A WDFY3 GOLGA2 | 2.34e-04 | 344 | 121 | 9 | int:ATG5 |
| Interaction | LRRC31 interactions | 2.41e-04 | 205 | 121 | 7 | int:LRRC31 | |
| Interaction | MYH6 interactions | 2.57e-04 | 94 | 121 | 5 | int:MYH6 | |
| Interaction | MYH3 interactions | 2.68e-04 | 52 | 121 | 4 | int:MYH3 | |
| Interaction | FOXP3 interactions | 2.81e-04 | 432 | 121 | 10 | int:FOXP3 | |
| Interaction | SLMAP interactions | 2.82e-04 | 149 | 121 | 6 | int:SLMAP | |
| Interaction | NPM1 interactions | ABCC1 MYH7 SENP3 EXOSC8 RPS23 CHMP4B ADARB1 NCAPG NF1 CEBPZ EIF4G1 ASPM PRKCZ FAM9A DNAJA1 GOLGA2 EPAS1 FTSJ3 | 2.93e-04 | 1201 | 121 | 18 | int:NPM1 |
| Interaction | GPR17 interactions | 3.13e-04 | 283 | 121 | 8 | int:GPR17 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q13 | 7.53e-05 | 82 | 124 | 4 | chr13q13 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.07e-04 | 4 | 77 | 2 | 1252 | |
| GeneFamily | Rho GTPase activating proteins|F-BAR domain containing | 1.24e-04 | 23 | 77 | 3 | 1288 | |
| GeneFamily | Keratins, type II | 2.02e-04 | 27 | 77 | 3 | 609 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 6.32e-04 | 9 | 77 | 2 | 1230 | |
| GeneFamily | PHD finger proteins|NuRD complex | 1.15e-03 | 12 | 77 | 2 | 1305 | |
| GeneFamily | Mitogen-activated protein kinases | 1.35e-03 | 13 | 77 | 2 | 651 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.81e-03 | 15 | 77 | 2 | 82 | |
| GeneFamily | Myosin heavy chains | 1.81e-03 | 15 | 77 | 2 | 1098 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | HSPA4L ATAD5 PTBP2 ACTN2 MCM10 CHMP4B NEFL VAC14 LATS1 AKAP9 CEBPZ SRGAP1 ATAD2B CEP83 GKAP1 ASPM UTP20 MAPK10 DNAJA1 PROX1 | 5.10e-07 | 989 | 118 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | HSPA4L ATAD5 PTBP2 RPS23 SIN3A MCM10 AXIN2 NEFL NCAPG AKAP9 CEBPZ CCDC149 FER1L4 CEP83 ASPM PRORP MAPK11 CMAHP DNAJA1 DNMT3B PROX1 FTSJ3 | 4.45e-06 | 1347 | 118 | 22 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | ATAD5 PTBP2 RPS23 SIN3A MCM10 AXIN2 NEFL NCAPG AKAP9 CEBPZ CCDC149 CEP83 ASPM PRORP MAPK11 CMAHP DNAJA1 DNMT3B PROX1 FTSJ3 | 6.14e-06 | 1164 | 118 | 20 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | FOXR1 SWT1 HSPA4L SENP3 MGAT4A ALS2 SIN3A PNLDC1 MCM10 NCAPG RBM27 CEBPZ NAE1 UTP20 PRKCZ FTSJ3 | 8.45e-06 | 795 | 118 | 16 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | ATAD5 PTBP2 CHMP4B LATS1 AKAP9 CEBPZ SRGAP1 ATAD2B CEP83 ASPM | 9.49e-06 | 311 | 118 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | FOXR1 SWT1 HSPA4L SENP3 MGAT4A ALS2 SIN3A PNLDC1 MCM10 NCAPG RBM27 NAE1 UTP20 PRORP RAD17 FTSJ3 | 1.07e-05 | 810 | 118 | 16 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.71e-05 | 333 | 118 | 10 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K3 | SWT1 ATAD5 PTBP2 SIN3A DTX3L MCM10 DOCK5 NEFL VAC14 NCAPG AKAP9 CEP83 UTP20 IRS2 PRORP MAPK11 CADPS2 CMAHP DNAJA1 DNMT3B FTSJ3 | 2.00e-05 | 1371 | 118 | 21 | facebase_RNAseq_e8.5_FloorPlate_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | HSPA4L ATAD5 PTBP2 RPS23 GSN LATS1 AKAP9 RBM27 CEBPZ ATAD2B CEP83 GKAP1 ASPM UTP20 MAPK10 DNAJA1 GOLGA2 | 3.06e-05 | 983 | 118 | 17 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000 | FOXR1 SWT1 HSPA4L SENP3 ALS2 SIN3A PNLDC1 MCM10 VAC14 NCAPG RBM27 NAE1 GKAP1 UTP20 PRKCZ | 5.11e-05 | 822 | 118 | 15 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | SWT1 ATAD5 DNAJC8 PTBP2 EXOSC8 MCM10 CHMP4B GTF2H2 NCAPG AKAP9 RBM27 ATAD2B CEP83 ASPM UTP20 MAPK11 CMAHP DNAJA1 FTSJ3 | 6.28e-05 | 1257 | 118 | 19 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 9.18e-05 | 328 | 118 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | TNIK KRT6A MYH7 MYH8 GJD2 MGAT4A DTX3L GSN NEFL PIK3C2A FER1L4 TACC1 FBXO32 MAPK10 | 9.89e-05 | 772 | 118 | 14 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 1.00e-04 | 192 | 118 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | HSPA4L ATAD5 PTBP2 NEFL AKAP9 CEP83 GKAP1 ASPM MAPK10 DNAJA1 PROX1 | 1.06e-04 | 498 | 118 | 11 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | SWT1 HSPA4L ATAD5 DNAJC8 PTBP2 EXOSC8 MCM10 CHMP4B GTF2H2 NCAPG AKAP9 RBM27 ATAD2B CEP83 ASPM UTP20 MAPK11 CMAHP DNAJA1 FTSJ3 | 1.50e-04 | 1459 | 118 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ABCC1 ATAD5 PTBP2 GTF2H2 NCAPG RBM27 CEBPZ CEP83 ASPM DNAJA1 FTSJ3 | 1.88e-04 | 532 | 118 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | SGSM1 HSPA4L ATAD5 PTBP2 ZFC3H1 NEFL GTF2H2 AKAP9 CCDC149 CEP83 GKAP1 ASPM IRS2 WDFY3 ST8SIA4 MAPK11 CADPS2 DNAJA1 PROX1 | 1.93e-04 | 1370 | 118 | 19 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | SWT1 ATAD5 DNAJC8 PTBP2 MCM10 NEFL SYNE3 AKAP9 ATAD2B CEP83 ASPM CMAHP DNAJA1 GOLGA2 PROX1 FTSJ3 | 2.57e-04 | 1060 | 118 | 16 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#5 | 3.20e-04 | 232 | 118 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_500 | 3.21e-04 | 388 | 118 | 9 | gudmap_developingLowerUrinaryTract_P1_bladder_500_J | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_emap-3087_k-means-cluster#2_top-relative-expression-ranked_100 | 3.52e-04 | 25 | 118 | 3 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr mesench_100_k2 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_1000 | 4.23e-04 | 243 | 118 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | HSPA4L ATAD5 PTBP2 AKAP9 CEP83 GKAP1 ASPM UTP20 MAPK10 DNAJA1 | 4.32e-04 | 493 | 118 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.62e-07 | 177 | 124 | 7 | 844017225e9039d1bc621a9630a30c2e9a51b36d | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.62e-07 | 177 | 124 | 7 | 26c25d10aa511b64cc7db43a8deea7b5d31bca96 | |
| ToppCell | severe-Myeloid-Eosinophils|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.23e-06 | 170 | 124 | 6 | 863f0266d5837cdbc3e09a3fe6a99dd3e6261674 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.09e-06 | 173 | 124 | 6 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.37e-05 | 186 | 124 | 6 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 1.50e-05 | 189 | 124 | 6 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 189 | 124 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 190 | 124 | 6 | 656483751e4bf137e4e4bfb2a03a478a8f7fcb63 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-05 | 194 | 124 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.79e-05 | 195 | 124 | 6 | fc95457a298b5d0dab687d9ee7e225a7f7b9a0d4 | |
| ToppCell | ILEUM-inflamed-(6)_ILC3|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.79e-05 | 195 | 124 | 6 | c6968da7d2b60c2163e1ff0ffa41340e1ec1d2ed | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.79e-05 | 195 | 124 | 6 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.90e-05 | 197 | 124 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.95e-05 | 198 | 124 | 6 | a860246bcea847249a78fd2e86ed8e04371060db | |
| ToppCell | Transverse-B_cell-B_cell_cycling|B_cell / Region, Cell class and subclass | 2.01e-05 | 199 | 124 | 6 | 170ae68963d31f3b821b6f0e8f0c039bea0bc981 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.43e-05 | 132 | 124 | 5 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-CD45____NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-05 | 163 | 124 | 5 | a763c1632d6465a1e753bdc8eadaf819d2b09e5e | |
| ToppCell | droplet-Kidney-nan-3m-Lymphocytic-NK_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-05 | 163 | 124 | 5 | eaed783eecd07aafa5af844b63c9d816b4da99e4 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.17e-04 | 171 | 124 | 5 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 171 | 124 | 5 | b0373ed8283ee1792b6a490bff93906546978593 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.17e-04 | 171 | 124 | 5 | b92963f9f247d2e5e2e6c51c6dbf70e527cd2f55 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.20e-04 | 172 | 124 | 5 | ef33b5e0515c6d29fb6d9a673011c1b68ef264f3 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 174 | 124 | 5 | 72df66319f6efbd88ecf439013d97409fbf3cb52 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 174 | 124 | 5 | c6087fd0e036ec7f40f0f8f17d1f6ce13ddb5235 | |
| ToppCell | Basal-basal-3|World / Class top | 1.30e-04 | 175 | 124 | 5 | a0d7ced5204a9efbbb91ac99410a088f8ed2df0f | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.30e-04 | 175 | 124 | 5 | 74800a10f5ff25d5414fbccb0668f92ff077d1cc | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.41e-04 | 178 | 124 | 5 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.45e-04 | 179 | 124 | 5 | 252328c9ce9bf61f741a4ebe170c93733c8747b6 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_4|COVID-19_Convalescent / Disease condition and Cell class | 1.45e-04 | 179 | 124 | 5 | 366e4a31db9e80fd1770ac9f1ae148fefeb9f7df | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.49e-04 | 180 | 124 | 5 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 1.52e-04 | 181 | 124 | 5 | 1168164994d5e2072c80d058e42aab72a0cf9867 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-04 | 182 | 124 | 5 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 1.60e-04 | 183 | 124 | 5 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.65e-04 | 184 | 124 | 5 | 9cbfb9f09476b4d09eb8f92c6f21e449dabcfa98 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.65e-04 | 184 | 124 | 5 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell-4|TCGA-Uvea / Sample_Type by Project: Shred V9 | 1.65e-04 | 184 | 124 | 5 | 9c56753e5e668be888662e4713cf4ce44e6c58fb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-04 | 185 | 124 | 5 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 1.77e-04 | 187 | 124 | 5 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 1.77e-04 | 187 | 124 | 5 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-04 | 188 | 124 | 5 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 188 | 124 | 5 | e0184d9f6687d7ecb8fc461294ff7208f49c437c | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.82e-04 | 188 | 124 | 5 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.82e-04 | 188 | 124 | 5 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 190 | 124 | 5 | 8f5e71a0861ee4e8f3ce45e8a7f18fb9d6036a3c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 190 | 124 | 5 | 84265be128170cbb08d76e824aa108e07da9c3e5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.91e-04 | 190 | 124 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 1.91e-04 | 190 | 124 | 5 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | Control-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.96e-04 | 191 | 124 | 5 | 11dfd8f38beb294f42710cfbd355cb089e1023c0 | |
| ToppCell | COPD-Myeloid-cDC2|COPD / Disease state, Lineage and Cell class | 1.96e-04 | 191 | 124 | 5 | 2af6e4a6bd1f2193ece2131c3b7d976dd23a6966 | |
| ToppCell | ILEUM-non-inflamed-(6)_ILC3|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.96e-04 | 191 | 124 | 5 | 6eaf72b41084404bee0db04e4605db745a74995f | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 1.96e-04 | 191 | 124 | 5 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | RA-09._Endothelium_I|World / Chamber and Cluster_Paper | 1.96e-04 | 191 | 124 | 5 | c8a0c2af119bc34a8f694a7d30642f28002c84b9 | |
| ToppCell | COPD-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.01e-04 | 192 | 124 | 5 | 984cdc2f1d93e164bc946d63f58dacb629f82eb7 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 2.01e-04 | 192 | 124 | 5 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | RA-09._Endothelium_I|RA / Chamber and Cluster_Paper | 2.01e-04 | 192 | 124 | 5 | 8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc | |
| ToppCell | IPF-Myeloid-cDC2|IPF / Disease state, Lineage and Cell class | 2.01e-04 | 192 | 124 | 5 | fe1de692fec48cba4a9bbc6eaa257260e8b4e800 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 193 | 124 | 5 | 3eaa0461618582a1754400624350d269d24e750a | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 2.05e-04 | 193 | 124 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COPD-Myeloid-ncMonocyte|COPD / Disease state, Lineage and Cell class | 2.05e-04 | 193 | 124 | 5 | 936ca95995599356b794fba32bfd82d8de339365 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.05e-04 | 193 | 124 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.05e-04 | 193 | 124 | 5 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.05e-04 | 193 | 124 | 5 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.05e-04 | 193 | 124 | 5 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | Control-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.05e-04 | 193 | 124 | 5 | 4cb938c346cc32ec122d11e6b9f25db20e0f7ff6 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.05e-04 | 193 | 124 | 5 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | RV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.05e-04 | 193 | 124 | 5 | e3fa47e2c7cd8a5b69186711c57751f2296de8ae | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 193 | 124 | 5 | 287e756d5fd3bd2931c168da24beaa0d02a350ae | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.10e-04 | 194 | 124 | 5 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.10e-04 | 194 | 124 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-04 | 194 | 124 | 5 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | IPF-Myeloid-cDC2|Myeloid / Disease state, Lineage and Cell class | 2.10e-04 | 194 | 124 | 5 | accf4b7b09e2048f2e47a52201e0158684dda8fe | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-J_(AT1-AT2_progenitors)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.10e-04 | 194 | 124 | 5 | 4d6ae2b25db11a4ae6dadee83be5c8c05b1225c3 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 2.15e-04 | 195 | 124 | 5 | 751cb00b0f3005be6b645adadfbb9dd2215b6e08 | |
| ToppCell | LV-09._Endothelium_I|World / Chamber and Cluster_Paper | 2.15e-04 | 195 | 124 | 5 | 19e0a6c3eae1615aaa39767300acd937dfcb2a7f | |
| ToppCell | (1)_T_cells-(1)_T_cells_Dividing|(1)_T_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.15e-04 | 195 | 124 | 5 | cf00a0b4f341f0487d5b37810abe2952fdd3f6f2 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.21e-04 | 196 | 124 | 5 | 5bb8653af62334ded8aad48b24b64d7b54bc3cd5 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 196 | 124 | 5 | b04ca69b0ed44e09c989b575f747e1e819cd8008 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.21e-04 | 196 | 124 | 5 | 279f43deeba4528cd63f5217a8441b5452bf0b16 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 196 | 124 | 5 | a31e227de2dc077b81881295b012d22fedbd65ed | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 197 | 124 | 5 | fb272c9c60ee3d980e528044dc567b4925a23da6 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-04 | 197 | 124 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-04 | 197 | 124 | 5 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 197 | 124 | 5 | 61c0d78b29dc4ad8a84172cbfcdab03f31351d0e | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 197 | 124 | 5 | dcabea5c50c133c9a4e294e447462d0393174ea7 | |
| ToppCell | LA-09._Endothelium_I|LA / Chamber and Cluster_Paper | 2.26e-04 | 197 | 124 | 5 | ab6d1ab586a188597a39854ef980b8955ebcc645 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.26e-04 | 197 | 124 | 5 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 2.26e-04 | 197 | 124 | 5 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.26e-04 | 197 | 124 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Trm_Th1/Th17|GI_small-bowel / Manually curated celltypes from each tissue | 2.31e-04 | 198 | 124 | 5 | f4fc0cac858fc6dcd779d7959ccec51f78ea8cc2 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-04 | 198 | 124 | 5 | e06d41a7254a09e037ec404be2d8c352d5cbd7f4 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 2.31e-04 | 198 | 124 | 5 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 198 | 124 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Bronchial_Biopsy|World / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.31e-04 | 198 | 124 | 5 | f5b7013045b61fc56894f80092f799770dde1c8f | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.31e-04 | 198 | 124 | 5 | f088badb90c6c2d916195f5649eda102119c9ac6 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.37e-04 | 199 | 124 | 5 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | proximal-Epithelial-Proliferating_Basal|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.37e-04 | 199 | 124 | 5 | 521ff4ae3437c8ba477a0a42b9da195af976c3ff | |
| ToppCell | (4)_Endothelial_cells-(4)_Blood_vessel|(4)_Endothelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.37e-04 | 199 | 124 | 5 | e24d70e79f25cdd3300bf5e2322713355264d4c5 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|T_cell / Region, Cell class and subclass | 2.37e-04 | 199 | 124 | 5 | 7cfe9b2538ea008d67343f3e8bfec3bf81200de6 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.37e-04 | 199 | 124 | 5 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | COVID-19-Lymphoid-Proliferating_CD4_T_cells|Lymphoid / Condition, Lineage and Cell class | 2.37e-04 | 199 | 124 | 5 | 2e9ee10a069afca5dbd9f0863cf90a66db1a6ffb | |
| Drug | mant-GTP | 8.80e-09 | 50 | 122 | 7 | CID000128647 | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; HL60; HT_HG-U133A | 1.19e-06 | 197 | 122 | 9 | 2544_DN | |
| Drug | SC-791 | 2.97e-06 | 6 | 122 | 3 | CID010291510 | |
| Drug | Olux | 3.56e-06 | 20 | 122 | 4 | CID000032797 | |
| Drug | MK-6 | 7.67e-06 | 24 | 122 | 4 | CID005283547 | |
| Drug | SC-560; Up 200; 10uM; PC3; HT_HG-U133A | 1.09e-05 | 196 | 122 | 8 | 6865_UP | |
| Disease | Pachyonychia congenita syndrome | 9.46e-05 | 4 | 118 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 9.46e-05 | 4 | 118 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 9.46e-05 | 4 | 118 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 9.46e-05 | 4 | 118 | 2 | C1721007 | |
| Disease | arthrogryposis multiplex congenita (is_implicated_in) | 9.46e-05 | 4 | 118 | 2 | DOID:0080954 (is_implicated_in) | |
| Disease | Pachyonychia Congenita | 1.57e-04 | 5 | 118 | 2 | C0265334 | |
| Disease | amyotrophic lateral sclerosis (is_implicated_in) | 2.84e-04 | 32 | 118 | 3 | DOID:332 (is_implicated_in) | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.29e-04 | 7 | 118 | 2 | C0751337 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 4.32e-04 | 157 | 118 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | ABCC1 ABCA12 SYNE1 AXIN2 NCAPG NF1 AKAP9 EIF4G1 PRKCZ ST8SIA4 | 5.30e-04 | 702 | 118 | 10 | C0009402 |
| Disease | renin measurement, hypertension | 5.60e-04 | 9 | 118 | 2 | EFO_0000537, EFO_0010616 | |
| Disease | mean fractional anisotropy measurement | 5.84e-04 | 95 | 118 | 4 | EFO_0008399 | |
| Disease | subiculum volume | 6.85e-04 | 43 | 118 | 3 | EFO_0009399 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 6.99e-04 | 10 | 118 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 7.48e-04 | 268 | 118 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.02e-03 | 12 | 118 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.02e-03 | 12 | 118 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.02e-03 | 12 | 118 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.20e-03 | 13 | 118 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | ABCC1 SYNE1 TRPC4 SPTLC1 DTX3L GSN NF1 AKAP9 PER2 UTP20 FLACC1 DNMT3B | 1.26e-03 | 1074 | 118 | 12 | C0006142 |
| Disease | susceptibility to common cold measurement | 1.33e-03 | 54 | 118 | 3 | EFO_0008417 | |
| Disease | glycerol-3-phosphate measurement | 1.61e-03 | 15 | 118 | 2 | EFO_0010488 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.61e-03 | 15 | 118 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | Arsenic Induced Polyneuropathy | 1.99e-03 | 62 | 118 | 3 | C0751852 | |
| Disease | Arsenic Encephalopathy | 1.99e-03 | 62 | 118 | 3 | C0751851 | |
| Disease | Arsenic Poisoning | 1.99e-03 | 62 | 118 | 3 | C0311375 | |
| Disease | Arsenic Poisoning, Inorganic | 1.99e-03 | 62 | 118 | 3 | C0274861 | |
| Disease | Nervous System, Organic Arsenic Poisoning | 1.99e-03 | 62 | 118 | 3 | C0274862 | |
| Disease | taurocholate measurement | 2.87e-03 | 20 | 118 | 2 | EFO_0010538 | |
| Disease | Headache, HbA1c measurement | 3.17e-03 | 21 | 118 | 2 | EFO_0004541, HP_0002315 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.30e-03 | 152 | 118 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Dermatologic disorders | 3.41e-03 | 75 | 118 | 3 | C0037274 | |
| Disease | Primary familial hypertrophic cardiomyopathy | 3.48e-03 | 22 | 118 | 2 | cv:C0949658 | |
| Disease | Immunologic Deficiency Syndromes | 3.80e-03 | 23 | 118 | 2 | C0021051 | |
| Disease | Hereditary Paraganglioma-Pheochromocytoma Syndrome | 3.80e-03 | 23 | 118 | 2 | C1708353 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ALKKCAQDYLARVKQ | 711 | O75410 | |
| LKRQIAKKAAALDVY | 846 | Q96QE3 | |
| ALSNKLKLKRQLEYE | 701 | Q99814 | |
| LRAESFRKALIYQKK | 3706 | Q99996 | |
| INDLVKKYKLSRAFV | 481 | O95394 | |
| LAVDAAYAKKQKREV | 431 | Q6ZSZ5 | |
| KIANVNKALDYIASK | 96 | P35609 | |
| KLAVRGAQAKRKSIY | 281 | Q9UKL4 | |
| LQDCLEYNRIAKLKK | 756 | Q9UBC3 | |
| RLLQEAVKEIKSYLK | 1406 | Q96Q42 | |
| IAAFVKKLVYEKDLR | 1081 | Q86UK0 | |
| NLKDTKTLRVAKAIY | 121 | Q9Y2T1 | |
| AKYKEVKARNAQLLK | 281 | Q5VSY0 | |
| EQLAREKVYLCQKLK | 211 | Q9Y592 | |
| LQALKRKKRYEKQLA | 66 | Q9H444 | |
| LQALKRKKRYEKQLA | 26 | P59074 | |
| NATQEELKKAYRKLA | 16 | P31689 | |
| FQAQKLYKRRKESIL | 1501 | Q8IZT6 | |
| AKRAAKRVKIVYQDL | 686 | Q06278 | |
| KEIVRRKAVLALYKF | 181 | Q9UPM8 | |
| NFKKEVRNKIYSRLL | 1966 | Q6ZS30 | |
| SALANYVVALVKKDK | 26 | Q9P2N5 | |
| NKQAYDLAKALLKRT | 211 | Q9NTI5 | |
| YIQQKRLKAAEADSK | 316 | O94776 | |
| RLKAAEADSKLKQVY | 321 | O94776 | |
| LINKKYRENCLAAKA | 531 | O75943 | |
| RLVALKKFVAVLAKY | 326 | O00391 | |
| LAEVNLKKKSYLNIR | 176 | Q96B26 | |
| VAYFKINKLEKAVAA | 151 | Q32P28 | |
| LQLKVKAYKRQAEEA | 1871 | P12883 | |
| KEKLIAYQREFLALK | 31 | Q9UM21 | |
| YSLRNKELKDALRKA | 291 | Q8NGI7 | |
| KAKQDLARLLKEYQE | 436 | P48668 | |
| AYDARLRQKVAVKKL | 41 | Q15759 | |
| AYDAVLDRNVAIKKL | 81 | P53779 | |
| NYKAALKAEKLAAQE | 191 | Q96Q35 | |
| KAKQDLARLLKEYQE | 436 | P02538 | |
| YATKTLRKKDVLLRN | 731 | O95835 | |
| ASKVKKYRKLILEQA | 1361 | Q9ULI0 | |
| KAVATLKIYNRSLKE | 1166 | A9Z1Z3 | |
| VIYSIDKAKKFRLNR | 386 | Q96A33 | |
| VDKLQAKVKSYKRQA | 1871 | P13535 | |
| ATLKYALRSVKQVKA | 136 | O15055 | |
| KAKQDLARLLKEYQE | 436 | P04259 | |
| IKDVAAKRKIELNSY | 1496 | O00443 | |
| AELAARKYKQAAKCL | 256 | Q13098 | |
| VQAQYKKLSAKRADL | 416 | Q7L590 | |
| LDKVYNRAIKAAKSA | 146 | Q96RD7 | |
| VAQVDSLKDKARKLY | 86 | Q9NRR1 | |
| SKLAAKEYQAAKARL | 701 | P78563 | |
| KLAAAKKKLREYQQR | 21 | Q08379 | |
| RLLKKFKVVASGLNY | 1786 | A2RRP1 | |
| YSLRNKEIKDALKRL | 291 | Q8NGI8 | |
| SLRNRYLKGALKKVV | 291 | O43749 | |
| YSSRNKEVKAALKRL | 291 | Q9H209 | |
| AALIAEALKKKFAYR | 271 | Q15390 | |
| TRKLLNVLKEYIAEK | 171 | Q8IZU1 | |
| INKRADAKHKYLIAL | 101 | Q9Y4H2 | |
| AYKLRAARLVEIAAK | 486 | Q15067 | |
| LLKSNIAKYKNALER | 181 | Q6ZUS6 | |
| LLKKRASFYENIIKA | 1341 | Q9H7D0 | |
| LKIDLAAQYIKAAVK | 2836 | Q9UFH2 | |
| RKVLKLLYRAFDQKL | 671 | Q8TDB6 | |
| EKLGQKYRVALRIAK | 111 | Q9Y324 | |
| DFLARYRLVSNKLKK | 21 | P23610 | |
| LAEQKLARYKLRIVK | 16 | Q6PIV2 | |
| FIALAYSLKVRDKKL | 171 | A6NMD0 | |
| YSLKVRDKKLLNDLN | 176 | A6NMD0 | |
| KVVRKCLEKAALINY | 801 | Q86UW7 | |
| VAVLKARAKLLQKYL | 1501 | Q04637 | |
| ARAKLLQKYLCDEQK | 1506 | Q04637 | |
| AYKLLLDQEQKKRAL | 106 | O75937 | |
| DAANRKLAKLYKVSN | 291 | P06396 | |
| LRQKVAYLDKEFSKA | 41 | Q4V328 | |
| LFNSLNYDVAAKKRK | 51 | Q969P5 | |
| NIIKVAAKKYRDFDI | 191 | O15247 | |
| YKSLKADIVLRRVKA | 571 | Q03701 | |
| KLQAKCAVLEAKYLR | 56 | A6NFF2 | |
| YSLRNKDVKAAVKNI | 296 | Q8NGS7 | |
| IRQEELKVLKKSAYL | 531 | P33527 | |
| AADKAAIRKELNEYK | 526 | Q96KR7 | |
| NIYDLIKTLKAAKIR | 181 | Q6P1K8 | |
| NAVRALKSLSKKYRL | 41 | O60763 | |
| IKKLAALNVTEKDYR | 1501 | O75691 | |
| RALNDKLYEKRKVAA | 16 | Q08AM6 | |
| ENKLKSIKARNEYLL | 231 | Q7Z6B7 | |
| AKALVVKALKAFVRD | 66 | Q8N2E6 | |
| QRVKILYNKKDSALI | 366 | Q9UKA9 | |
| EALKKLALALQERKY | 4276 | Q8NF91 | |
| YDAVKAKAQKRVDLL | 201 | Q6ZMZ3 | |
| YSLRNKDVKKALIKV | 341 | Q8NGC0 | |
| LTNKFKDARNILKEY | 461 | Q8NA58 | |
| KSNVLRKLLKRANSY | 66 | Q92786 | |
| RRYVAKKLKEQAKAL | 316 | Q8IY81 | |
| RKALQRIYADKAADI | 666 | Q96ST3 | |
| NALILKNKLKVRTAY | 241 | Q92187 | |
| ENKLKAIKARNEYLL | 241 | P0DMP2 | |
| QVLAKVKRAVVYLDA | 16 | Q8WU76 | |
| RLKAAEAESKLKQVY | 341 | Q13330 | |
| LYKNLRKANKAVDFT | 651 | Q5T5J6 | |
| TKATNLIAKARYLRK | 56 | O15091 | |
| RVKAAALASLKKYGV | 116 | O15269 | |
| KLNKSAVLRKAIDYI | 356 | P36956 | |
| ERKKLLNYKARLVKN | 231 | Q9Y471 | |
| KEAVRKLAYQVLAEK | 221 | Q9BPX3 | |
| AKYLQAEAVKKDRLD | 496 | Q9H4L4 | |
| AKALVVKALKAFVRD | 66 | Q5JU69 | |
| ANVSLLALYKGKKER | 126 | P62266 | |
| AEIKIIREAYKKAFL | 11 | Q8N0X7 | |
| KYERIKFLVIALKNA | 1151 | Q9UKE5 | |
| RFYKVLTAEQKAKAL | 66 | Q9HA47 | |
| VARIRKVYNKLDSKA | 1336 | Q8IZQ1 | |
| ERANKLVKYLLVKDQ | 446 | Q12816 | |
| NIYDLIKTLKAAKIR | 181 | Q13888 | |
| KYKINVKENSRALLR | 251 | O95757 | |
| ENKLKAIKARNEYLL | 241 | O75044 | |
| LAKLKRNYAKAVELL | 131 | Q9Y5K8 | |
| QYINVDCAKLKRLLK | 181 | P21359 | |
| NTKQVLKLARDLVYK | 1126 | Q2NKQ1 | |
| LVNLLTRYKIAEKKV | 1766 | Q9P2E3 | |
| KALQDKKYEDAVRNL | 281 | Q6PGP7 | |
| KKEAANAYQRAILLL | 996 | Q6PGP7 | |
| KAKEAYLKALELDRN | 581 | Q6ZXV5 | |
| AFRKAYSIKDKLQAI | 51 | Q53EQ6 | |
| KLQNVYREKAKKDAA | 341 | Q13564 | |
| YALKIQKLKEARALK | 976 | O60293 | |
| LARLKLAIKYRQKEF | 286 | Q9UBN4 | |
| ALYVVDLKKFRKIAA | 1416 | Q9NYU2 | |
| LANIEKEFKNDYRKL | 236 | Q13507 | |
| CYALVKEEAAKLKAR | 1016 | Q9Y6N6 | |
| GSYAKVLLVRLKKND | 261 | Q05513 | |
| AALKDIRAQYEKLAA | 256 | P07196 |